Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > More acquisition in the works?

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Nov 04, 2021 12:36pm

91 Views

Post# 34087339

RE:More acquisition in the works?

The question is will they pay for those acquisitions through more dilution further degrading share value.......but hey......FSD was never one to let share value get in the way....

DavidRosenberg wrote: I wonder if they will do more acquisitions

Personally I think LUCID is enough because they can research many molecules over at UHN if needed.

Thats like a one stop shop for everything related to R&D for drugs.

Lucid MS and Lucid Psych for Major Depressive Disorder